Status:
COMPLETED
CCC Project - Atrial Fibrillation
Lead Sponsor:
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Collaborating Sponsors:
American Heart Association
Chinese Society of Cardiology
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
Brief Summary
The purpose of this study is to develop and implement quality improvement programs for the treatment of atrial fibrillation (AF) in China based on the successful experience of the AHA-Get with the Gui...
Eligibility Criteria
Inclusion
- Hospitalized patients with discharge diagnosis as atrial fibrillation in 150 tertiary and 100 secondary hospitals.
Exclusion
- None
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2020
Estimated Enrollment :
67028 Patients enrolled
Trial Details
Trial ID
NCT02309398
Start Date
January 1 2015
End Date
December 1 2020
Last Update
January 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing An Zhen Hospital
Beijing, China